Intestinal Serotonin Release, Sensory Neuron Activation, and Abdominal Pain in Irritable Bowel Syndrome

被引:207
作者
Cremon, Cesare [1 ,2 ]
Carini, Giovanni [1 ,2 ]
Wang, Bingxian [3 ]
Vasina, Valentina [4 ]
Cogliandro, Rosanna F. [1 ,2 ]
De Giorgio, Roberto [1 ,2 ]
Stanghellini, Vincenzo [1 ,2 ]
Grundy, David [5 ]
Tonini, Marcello [6 ]
De Ponti, Fabrizio [4 ]
Corinaldesi, Roberto [1 ,2 ]
Barbara, Giovanni [1 ,2 ]
机构
[1] Univ Bologna, Dept Clin Med, Bologna, Italy
[2] Univ Bologna, Ctr Appl Biomed Res, Bologna, Italy
[3] St Josephs Healthcare, McMaster Brain Body Inst, Hamilton, ON, Canada
[4] Univ Bologna, Dept Pharmacol, Bologna, Italy
[5] Univ Sheffield, Dept Biomed Sci, Sheffield S10 2TN, S Yorkshire, England
[6] Univ Pavia, Dept Forens Med Pharmacol & Toxicol, I-27100 Pavia, Italy
关键词
ENTEROCHROMAFFIN CELL HYPERPLASIA; RAT JEJUNUM; PLASMA; 5-HYDROXYTRYPTAMINE; ENTEROENDOCRINE CELLS; ULCERATIVE-COLITIS; GUINEA-PIGS; MAST-CELLS; DISORDERS; PREDOMINANT; TRANSPORTER;
D O I
10.1038/ajg.2011.86
中图分类号
R57 [消化系及腹部疾病];
学科分类号
100201 [内科学];
摘要
OBJECTIVES: Serotonin (5-hydroxytryptamine, 5-HT) metabolism may be altered in gut disorders, including in the irritable bowel syndrome (IBS). We assessed in patients with IBS vs. healthy controls (HCs) the number of colonic 5-HT-positive cells; the amount of mucosal 5-HT release; their correlation with mast cell counts and mediator release, as well as IBS symptoms; and the effects of mucosal 5-HT on electrophysiological responses in vitro. METHODS: We enrolled 25 Rome II IBS patients and 12 HCs. IBS symptom severity and frequency were graded 0-4. 5-HT-positive enterochromaffin cells and tryptase-positive mast cells were assessed with quantitative immunohistochemistry on colonic biopsies. Mucosal 5-HT and mast cell mediators were assessed by high-performance liquid chromatography or immunoenzymatic assay, respectively. The impact of mucosal 5-HT on electrophysiological activity of rat mesenteric afferent nerves was evaluated in vitro. RESULTS: Compared with HCs, patients with IBS showed a significant increase in 5-HT-positive cell counts (0.37 +/- 0.16 % vs. 0.56 +/- 0.26 %; P = 0.039), which was significantly greater in patients with diarrhea-predominant IBS vs. constipation-predominant IBS (P = 0.035). Compared with HCs, 5-HT release in patients with IBS was 10-fold significantly increased (P < 0.001), irrespective of bowel habit, and was correlated with mast cell counts. A significant correlation was found between the mucosal 5-HT release and the severity of abdominal pain (r(s) = 0.582, P = 0.047). The area under the curve, but not peak sensory afferent discharge evoked by IBS samples in rat jejunum, was significantly inhibited by the 5-HT 3 receptor antagonist granisetron (P < 0.005). CONCLUSIONS: In patients with IBS, 5-HT spontaneous release was significantly increased irrespective of bowel habit and correlated with mast cell counts and the severity of abdominal pain. Our results suggest that increased 5-HT release contributes to development of abdominal pain in IBS, probably through mucosal immune activation.
引用
收藏
页码:1290 / 1298
页数:9
相关论文
共 49 条
[1]
Altered 5-hydroxytryptamine signaling in patients with constipation- and diarrhea-predominant irritable bowel syndrome [J].
Atkinson, W ;
Lockhart, S ;
Whorwell, PJ ;
Keevil, B ;
Houghton, LA .
GASTROENTEROLOGY, 2006, 130 (01) :34-43
[2]
Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome [J].
Barbara, G ;
Stanghellini, V ;
De Giorgio, R ;
Cremon, C ;
Cottrell, GS ;
Santini, D ;
Pasquinelli, G ;
Morselli-Labate, AM ;
Grady, EF ;
Bunnett, NW ;
Collins, SM ;
Corinalidesi, R .
GASTROENTEROLOGY, 2004, 126 (03) :693-702
[3]
New pathophysiological mechanisms in irritable bowel syndrome [J].
Barbara, G ;
De Giorgio, R ;
Stanghellini, V ;
Cremon, C ;
Salvioli, B ;
Corinaldesi, R .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2004, 20 :1-9
[4]
Mast cell-dependent excitation of visceral-nociceptive sensory neurons in irritable bowel syndrome [J].
Barbara, Giovanni ;
Wang, Bingxian ;
Stanghellini, Vincenzo ;
De Giorgio, Roberto ;
Cremon, Cesare ;
Di Nardo, Giovanni ;
Trevisani, Marcello ;
Campi, Barbara ;
Geppetti, Pierangelo ;
Tonini, Marcello ;
Bunnett, Nigel W. ;
Grundy, David ;
Corinaldesi, Roberto .
GASTROENTEROLOGY, 2007, 132 (01) :26-37
[5]
Postprandial plasma 5-hydroxytryptamine in diarrhoea predominant irritable bowel syndrome: a pilot study [J].
Bearcroft, CP ;
Perrett, D ;
Farthing, MJG .
GUT, 1998, 42 (01) :42-46
[6]
Activation of Human Enteric Neurons by Supernatants of Colonic Biopsy Specimens From Patients With Irritable Bowel Syndrome [J].
Buhner, Sabine ;
Li, Qin ;
Vignali, Sheila ;
Barbara, Giovanni ;
De Giorgio, Roberto ;
Stanghellini, Vincenzo ;
Cremon, Cesare ;
Zeller, Florian ;
Langer, Rupert ;
Daniel, Hannelore ;
Michel, Klaus ;
Schemann, Michael .
GASTROENTEROLOGY, 2009, 137 (04) :1425-1434
[7]
Efficacy and safety of alosetron in women with irritable bowel syndrome: a randomised, placebo-controlled trial [J].
Camilleri, M ;
Northcutt, AR ;
Kong, S ;
Dukes, GE ;
McSorley, D ;
Mangel, AW .
LANCET, 2000, 355 (9209) :1035-1040
[8]
Camilleri M, 1999, ALIMENT PHARM THERAP, V13, P1149
[9]
Alterations in expression of p11 and SERT in mucosal biopsy specimens of patients with irritable bowel syndrome [J].
Camilleri, Michael ;
Andrews, Christopher N. ;
Bharucha, Adil E. ;
Carlson, Paula J. ;
Ferber, Irene ;
Stephens, Debra ;
Smyrk, Thomas C. ;
Urrutia, Raul ;
Aerssens, Jeroen ;
Thielemans, Leen ;
Gohlmann, Hinrich ;
Van den Wyngaert, Ilse ;
Coulie, Bernard .
GASTROENTEROLOGY, 2007, 132 (01) :17-25
[10]
Pharmacological and pharmacokinetic aspects of functional gastrointestinal disorders [J].
Camilleri, Michael ;
Bueno, Lionel ;
de Ponti, Fabrizio ;
Fioramonti, Jean ;
Lydiard, R. Bruce ;
Tack, Jan .
GASTROENTEROLOGY, 2006, 130 (05) :1421-1434